Proteomic analyses reveal that loss of TDP-43 affects RNA processing and intracellular transport

Neuroscience

Volumn 293, Issue , 2015, Pages 157-170

  Stalekar M ^a,b   Yin, X ^b   Rebolj, K ^a   Darovic, S ^a,b   Troakes, C ^b   Mayr, M ^b   Shaw, C E ^b   Rogelj, B ^a,c  

^a JO EF STEFAN INSTITUTE   (Slovenia)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Biomedical Research Institute BRIS   (Slovenia)

Author keywords

Amyotrophic lateral sclerosis; Comparative proteomics; Frontotemporal lobar degeneration; Intracellular transport; RanBP1; TDP 43

Indexed keywords

BINDING PROTEIN; CHROMOGRANIN B; DNA METHYLTRANSFERASE 3A; PROTEOME; RAN BINDING PROTEIN 1; RNA; TAR DNA BINDING PROTEIN; TRANSPORTIN 1; UNCLASSIFIED DRUG; CARRIER PROTEIN; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA BINDING PROTEIN; KARYOPHERIN BETA; NUCLEAR PROTEIN; RAN-BINDING PROTEIN 1; TDP-43 PROTEIN, HUMAN; TNPO1 PROTEIN, HUMAN;

ARTICLE; CELL ASSAY; CELL LEVEL; CELL TRANSPORT; CONTROLLED STUDY; DATA ANALYSIS; DOWN REGULATION; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; RNA PROCESSING; SIGNAL TRANSDUCTION; VALIDATION PROCESS; GENETICS; METABOLISM; TUMOR CELL LINE;

BETA KARYOPHERINS; CARRIER PROTEINS; CELL LINE, TUMOR; CHROMOGRANIN B; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA-BINDING PROTEINS; HUMANS; NUCLEAR PROTEINS; PROTEOMICS; RNA;

EID: 84925307620     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.02.046     Document Type: Article

References (71)

1. Acharya K.K., Govind C.K., Shore A.N., Stoler M.H., Reddi P.P. Cis-requirement for the maintenance of round spermatid-specific transcription. Dev Biol 2006, 295:781-790.
2. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., Oda T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006, 351:602-611.
3. Ayala Y.M., Misteli T., Baralle F.E. TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression. Proc Natl Acad Sci U S A 2008, 105:3785-3789.
4. Banzhaf-Strathmann J., Claus R., Mucke O., Rentzsch K., van der Zee J., Engelborghs S., De Deyn P.P., Cruts M., van Broeckhoven C., Plass C., Edbauer D. Promoter DNA methylation regulates progranulin expression and is altered in FTLD. Acta Neuropathol Commun 2013, 1:16.
5. Bischoff F.R., Klebe C., Kretschmer J., Wittinghofer A., Ponstingl H. RanGAP1 induces GTPase activity of nuclear Ras-related Ran. Proc Natl Acad Sci U S A 1994, 91:2587-2591.
6. Bischoff F.R., Krebber H., Smirnova E., Dong W., Ponstingl H. Co-activation of RanGTPase and inhibition of GTP dissociation by Ran-GTP binding protein RanBP1. EMBO J 1995, 14:705-715.
7. Bose J.K., Huang C.C., Shen C.K. Regulation of autophagy by neuropathological protein TDP-43. J Biol Chem 2011, 286:44441-44448.
8. Brelstaff J., Lashley T., Holton J.L., Lees A.J., Rossor M.N., Bandopadhyay R., Revesz T. Transportin1: a marker of FTLD-FUS. Acta Neuropathol 2011, 122:591-600.
9. Buratti E., Baralle F.E. Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J Biol Chem 2001, 276:36337-36343.
10. Buratti E., De Conti L., Stuani C., Romano M., Baralle M., Baralle F. Nuclear factor TDP-43 can affect selected microRNA levels. FEBS J 2010, 277:2268-2281.
11. Chang J.C., Hazelett D.J., Stewart J.A., Morton D.B. Motor neuron expression of the voltage-gated calcium channel cacophony restores locomotion defects in a Drosophila, TDP-43 loss of function model of ALS. Brain Res 2014, 1584:39-51.
12. Chestnut B.A., Chang Q., Price A., Lesuisse C., Wong M., Martin L.J. Epigenetic regulation of motor neuron cell death through DNA methylation. J Neurosci 2011, 31:16619-16636.
13. Colombrita C., Zennaro E., Fallini C., Weber M., Sommacal A., Buratti E., Silani V., Ratti A. TDP-43 is recruited to stress granules in conditions of oxidative insult. J Neurochem 2009, 111:1051-1061.
14. Diaper D.C., Adachi Y., Lazarou L., Greenstein M., Simoes F.A., Di Domenico A., Solomon D.A., Lowe S., Alsubaie R., Cheng D., Buckley S., Humphrey D.M., Shaw C.E., Hirth F. Drosophila TDP-43 dysfunction in glia and muscle cells cause cytological and behavioural phenotypes that characterize ALS and FTLD. Hum Mol Genet 2013, 22:3883-3893.
15. Diaper D.C., Adachi Y., Sutcliffe B., Humphrey D.M., Elliott C.J., Stepto A., Ludlow Z.N., Vanden Broeck L., Callaerts P., Dermaut B., Al-Chalabi A., Shaw C.E., Robinson I.M., Hirth F. Loss and gain of Drosophila TDP-43 impair synaptic efficacy and motor control leading to age-related neurodegeneration by loss-of-function phenotypes. Hum Mol Genet 2013, 22:1539-1557.
16. Dormann D., Rodde R., Edbauer D., Bentmann E., Fischer I., Hruscha A., Than M.E., Mackenzie I.R., Capell A., Schmid B., Neumann M., Haass C. ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J 2010, 29:2841-2857.
17. Fiesel F.C., Voigt A., Weber S.S., Van den Haute C., Waldenmaier A., Gorner K., Walter M., Anderson M.L., Kern J.V., Rasse T.M., Schmidt T., Springer W., Kirchner R., Bonin M., Neumann M., Baekelandt V., Alunni-Fabbroni M., Schulz J.B., Kahle P.J. Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6. EMBO J 2010, 29:209-221.
18. Gendron T.F., Petrucelli L. Rodent models of TDP-43 proteinopathy: investigating the mechanisms of TDP-43-mediated neurodegeneration. J Mol Neurosci 2011, 45:486-499.
19. Gitcho M.A., Baloh R.H., Chakraverty S., Mayo K., Norton J.B., Levitch D., Hatanpaa K.J., White C.L., Bigio E.H., Caselli R., Baker M., Al-Lozi M.T., Morris J.C., Pestronk A., Rademakers R., Goate A.M., Cairns N.J. TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol 2008, 63:535-538.
20. Gros-Louis F., Andersen P.M., Dupre N., Urushitani M., Dion P., Souchon F., D'Amour M., Camu W., Meininger V., Bouchard J.P., Rouleau G.A., Julien J.P. Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 2009, 106:21777-21782.
21. Hazelett D.J., Chang J.C., Lakeland D.L., Morton D.B. Comparison of parallel high-throughput RNA sequencing between knockout of TDP-43 and its overexpression reveals primarily nonreciprocal and nonoverlapping gene expression changes in the central nervous system of Drosophila. G3 (Bethesda) 2012, 2:789-802.
22. Honda D., Ishigaki S., Iguchi Y., Fujioka Y., Udagawa T., Masuda A., Ohno K., Katsuno M., Sobue G. The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons. FEBS Open Bio 2014, 4:1-10.
23. Huang da W., Sherman B.T., Lempicki R.A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009, 37:1-13.
24. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57.
25. Iguchi Y., Katsuno M., Niwa J., Takagi S., Ishigaki S., Ikenaka K., Kawai K., Watanabe H., Yamanaka K., Takahashi R., Misawa H., Sasaki S., Tanaka F., Sobue G. Loss of TDP-43 causes age-dependent progressive motor neuron degeneration. Brain 2013, 136:1371-1382.
26. Izaurralde E., Kutay U., von Kobbe C., Mattaj I.W., Gorlich D. The asymmetric distribution of the constituents of the Ran system is essential for transport into and out of the nucleus. EMBO J 1997, 16:6535-6547.
27. Kabashi E., Lin L., Tradewell M.L., Dion P.A., Bercier V., Bourgouin P., Rochefort D., Bel Hadj S., Durham H.D., Vande Velde C., Rouleau G.A., Drapeau P. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum Mol Genet 2010, 19:671-683.
28. Kabashi E., Valdmanis P.N., Dion P., Spiegelman D., McConkey B.J., Vande Velde C., Bouchard J.P., Lacomblez L., Pochigaeva K., Salachas F., Pradat P.F., Camu W., Meininger V., Dupre N., Rouleau G.A. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 2008, 40:572-574.
29. Keller A., Nesvizhskii A.I., Kolker E., Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002, 74:5383-5392.
30. Kraemer B.C., Schuck T., Wheeler J.M., Robinson L.C., Trojanowski J.Q., Lee V.M., Schellenberg G.D. Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis. Acta Neuropathol 2010, 119:409-419.
31. Landen M., Grenfeldt B., Davidsson P., Stridsberg M., Regland B., Gottfries C.G., Blennow K. Reduction of chromogranin A and B but not C in the cerebrospinal fluid in subjects with schizophrenia. Eur Neuropsychopharmacol 1999, 9:311-315.
32. Lee J.C., Hook V. Proteolytic fragments of chromogranins A and B represent major soluble components of chromaffin granules, illustrated by two-dimensional proteomics with NH(2)-terminal Edman peptide sequencing and MALDI-TOF MS. Biochemistry 2009, 48:5254-5262.
33. Liu Y.C., Chiang P.M., Tsai K.J. Disease animal models of TDP-43 proteinopathy and their pre-clinical applications. Int J Mol Sci 2013, 14:20079-20111.
34. Mattsson N., Ruetschi U., Podust V.N., Stridsberg M., Li S., Andersen O., Haghighi S., Blennow K., Zetterberg H. Cerebrospinal fluid concentrations of peptides derived from chromogranin B and secretogranin II are decreased in multiple sclerosis. J Neurochem 2007, 103:1932-1939.
35. Melchior F., Paschal B., Evans J., Gerace L. Inhibition of nuclear protein import by nonhydrolyzable analogues of GTP and identification of the small GTPase Ran/TC4 as an essential transport factor. J Cell Biol 1993, 123:1649-1659.
36. Nesvizhskii A.I., Keller A., Kolker E., Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003, 75:4646-4658.
37. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., Lee V.M. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133.
38. Neumann M., Valori C.F., Ansorge O., Kretzschmar H.A., Munoz D.G., Kusaka H., Yokota O., Ishihara K., Ang L.C., Bilbao J.M., Mackenzie I.R. Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations. Acta Neuropathol 2012, 124:705-716.
39. Nishimura A.L., Zupunski V., Troakes C., Kathe C., Fratta P., Howell M., Gallo J.M., Hortobagyi T., Shaw C.E., Rogelj B. Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration. Brain 2010, 133:1763-1771.
40. Ou S.H., Wu F., Harrich D., Garcia-Martinez L.F., Gaynor R.B. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol 1995, 69:3584-3596.
41. Park Y.Y., Kim S.B., Han H.D., Sohn B.H., Kim J.H., Liang J., Lu Y., Rodriguez-Aguayo C., Lopez-Berestein G., Mills G.B., Sood A.K., Lee J.S. Tat-activating regulatory DNA-binding protein regulates glycolysis in hepatocellular carcinoma by regulating the platelet isoform of phosphofructokinase through microRNA 520. Hepatology 2013, 58:182-191.
42. Paronett E.M., Meechan D.W., Karpinski B.A., LaMantia A.S., Maynard T.M. Ranbp1, deleted in DiGeorge/22q11.2 deletion syndrome, is a microcephaly gene that selectively disrupts Layer 2/3 Cortical Projection Neuron Generation. Cereb Cortex 2014.
43. Polymenidou M., Lagier-Tourenne C., Hutt K.R., Huelga S.C., Moran J., Liang T.Y., Ling S.C., Sun E., Wancewicz E., Mazur C., Kordasiewicz H., Sedaghat Y., Donohue J.P., Shiue L., Bennett C.F., Yeo G.W., Cleveland D.W. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci 2011, 14:459-468.
44. Ruetschi U., Zetterberg H., Podust V.N., Gottfries J., Li S., Hviid Simonsen A., McGuire J., Karlsson M., Rymo L., Davies H., Minthon L., Blennow K. Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF. Exp Neurol 2005, 196:273-281.
45. Rutherford N.J., Zhang Y.J., Baker M., Gass J.M., Finch N.A., Xu Y.F., Stewart H., Kelley B.J., Kuntz K., Crook R.J., Sreedharan J., Vance C., Sorenson E., Lippa C., Bigio E.H., Geschwind D.H., Knopman D.S., Mitsumoto H., Petersen R.C., Cashman N.R., Hutton M., Shaw C.E., Boylan K.B., Boeve B., Graff-Radford N.R., Wszolek Z.K., Caselli R.J., Dickson D.W., Mackenzie I.R., Petrucelli L., Rademakers R. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet 2008, 4:e1000193.
46. Schmid B., Hruscha A., Hogl S., Banzhaf-Strathmann J., Strecker K., van der Zee J., Teucke M., Eimer S., Hegermann J., Kittelmann M., Kremmer E., Cruts M., Solchenberger B., Hasenkamp L., van Bebber F., Van Broeckhoven C., Edbauer D., Lichtenthaler S.F., Haass C. Loss of ALS-associated TDP-43 in zebrafish causes muscle degeneration, vascular dysfunction, and reduced motor neuron axon outgrowth. Proc Natl Acad Sci U S A 2013, 110:4986-4991.
47. Schrott-Fischer A., Bitsche M., Humpel C., Walcher C., Maier H., Jellinger K., Rabl W., Glueckert R., Marksteiner J. Chromogranin peptides in amyotrophic lateral sclerosis. Regul Pept 2009, 152:13-21.
48. Sephton C.F., Cenik C., Kucukural A., Dammer E.B., Cenik B., Han Y., Dewey C.M., Roth F.P., Herz J., Peng J., Moore M.J., Yu G. Identification of neuronal RNA targets of TDP-43-containing ribonucleoprotein complexes. J Biol Chem 2011, 286:1204-1215.
49. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996, 68:850-858.
50. Shiga A., Ishihara T., Miyashita A., Kuwabara M., Kato T., Watanabe N., Yamahira A., Kondo C., Yokoseki A., Takahashi M., Kuwano R., Kakita A., Nishizawa M., Takahashi H., Onodera O. Alteration of POLDIP3 splicing associated with loss of function of TDP-43 in tissues affected with ALS. PLoS One 2012, 7:e43120.
51. Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., Baralle F., de Belleroche J., Mitchell J.D., Leigh P.N., Al-Chalabi A., Miller C.C., Nicholson G., Shaw C.E. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008, 319:1668-1672.
52. Swarup V., Phaneuf D., Bareil C., Robertson J., Rouleau G.A., Kriz J., Julien J.P. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments. Brain 2011, 134:2610-2626.
53. Takeuchi R., Toyoshima Y., Tada M., Shiga A., Tanaka H., Shimohata M., Kimura K., Morita T., Kakita A., Nishizawa M., Takahashi H. Transportin 1 accumulates in FUS inclusions in adult-onset ALS without FUS mutation. Neuropathol Appl Neurobiol 2013, 39:580-584.
54. Tedeschi A., Ciciarello M., Mangiacasale R., Roscioli E., Rensen W.M., Lavia P. RANBP1 localizes a subset of mitotic regulatory factors on spindle microtubules and regulates chromosome segregation in human cells. J Cell Sci 2007, 120:3748-3761.
55. Tollervey J.R., Curk T., Rogelj B., Briese M., Cereda M., Kayikci M., Konig J., Hortobagyi T., Nishimura A.L., Zupunski V., Patani R., Chandran S., Rot G., Zupan B., Shaw C.E., Ule J. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci 2011, 14:452-458.
56. Troakes C., Hortobagyi T., Vance C., Al-Sarraj S., Rogelj B., Shaw C.E. Transportin 1 colocalization with Fused in Sarcoma (FUS) inclusions is not characteristic for amyotrophic lateral sclerosis-FUS confirming disrupted nuclear import of mutant FUS and distinguishing it from frontotemporal lobar degeneration with FUS inclusions. Neuropathol Appl Neurobiol 2013, 39:553-561.
57. Tsao W., Jeong Y.H., Lin S., Ling J., Price D.L., Chiang P.M., Wong P.C. Rodent models of TDP-43: recent advances. Brain Res 2012, 1462:26-39.
58. Van Deerlin V.M., Leverenz J.B., Bekris L.M., Bird T.D., Yuan W., Elman L.B., Clay D., Wood E.M., Chen-Plotkin A.S., Martinez-Lage M., Steinbart E., McCluskey L., Grossman M., Neumann M., Wu I.L., Yang W.S., Kalb R., Galasko D.R., Montine T.J., Trojanowski J.Q., Lee V.M., Schellenberg G.D., Yu C.E. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol 2008, 7:409-416.
59. Vizcaino J.A., Deutsch E.W., Wang R., Csordas A., Reisinger F., Rios D., Dianes J.A., Sun Z., Farrah T., Bandeira N., Binz P.A., Xenarios I., Eisenacher M., Mayer G., Gatto L., Campos A., Chalkley R.J., Kraus H.J., Albar J.P., Martinez-Bartolome S., Apweiler R., Omenn G.S., Martens L., Jones A.R., Hermjakob H. ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat Biotechnol 2014, 32:223-226.
60. Volkening K., Leystra-Lantz C., Yang W., Jaffee H., Strong M.J. Tar DNA binding protein of 43kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS). Brain Res 2009, 1305:168-182.
61. Wegorzewska I., Bell S., Cairns N.J., Miller T.M., Baloh R.H. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A 2009, 106:18809-18814.
62. Wilm M., Shevchenko A., Houthaeve T., Breit S., Schweigerer L., Fotsis T., Mann M. Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature 1996, 379:466-469.
63. Winton M.J., Igaz L.M., Wong M.M., Kwong L.K., Trojanowski J.Q., Lee V.M. Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J Biol Chem 2008, 283:13302-13309.
64. Wong M., Gertz B., Chestnut B.A., Martin L.J. Mitochondrial DNMT3A and DNA methylation in skeletal muscle and CNS of transgenic mouse models of ALS. Front Cell Neurosci 2013, 7:279.
65. Wu L.S., Cheng W.C., Shen C.K. Targeted depletion of TDP-43 expression in the spinal cord motor neurons leads to the development of amyotrophic lateral sclerosis-like phenotypes in mice. J Biol Chem 2012, 287:27335-27344.
66. Yang C., Wang H., Qiao T., Yang B., Aliaga L., Qiu L., Tan W., Salameh J., McKenna-Yasek D.M., Smith T., Peng L., Moore M.J., Brown R.H., Cai H., Xu Z. Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 2014, 111:E1121-E1129.
67. Yin X., Cuello F., Mayr U., Hao Z., Hornshaw M., Ehler E., Avkiran M., Mayr M. Proteomics analysis of the cardiac myofilament subproteome reveals dynamic alterations in phosphatase subunit distribution. Mol Cell Proteomics 2010, 9:497-509.
68. Yokoseki A., Shiga A., Tan C.F., Tagawa A., Kaneko H., Koyama A., Eguchi H., Tsujino A., Ikeuchi T., Kakita A., Okamoto K., Nishizawa M., Takahashi H., Onodera O. TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann Neurol 2008, 63:538-542.
69. Yu Z., Fan D., Gui B., Shi L., Xuan C., Shan L., Wang Q., Shang Y., Wang Y. Neurodegeneration-associated TDP-43 interacts with fragile X mental retardation protein (FMRP)/Staufen (STAU1) and regulates SIRT1 expression in neuronal cells. J Biol Chem 2012, 287:22560-22572.
70. Yudin D., Hanz S., Yoo S., Iavnilovitch E., Willis D., Gradus T., Vuppalanchi D., Segal-Ruder Y., Ben-Yaakov K., Hieda M., Yoneda Y., Twiss J.L., Fainzilber M. Localized regulation of axonal RanGTPase controls retrograde injury signaling in peripheral nerve. Neuron 2008, 59:241-252.
71. Zhou H., Huang C., Chen H., Wang D., Landel C.P., Xia P.Y., Bowser R., Liu Y.J., Xia X.G. Transgenic rat model of neurodegeneration caused by mutation in the TDP gene. PLoS Genet 2010, 6:e1000887.